ASHLEY CUOCO: Open Payments
NPI 1124743166 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 46 payments from 11 companies in 2025. Trend: 2023 $318 · 2024 $1,277 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $252 |
| Novartis Pharmaceuticals Corporation | 8 | $167 |
| MEDICOMP INC | 2 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $80 |
| Actelion Pharmaceuticals US, Inc. | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| HEARTFLOW, INC. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $35 |
Products named: REPATHA, LEQVIO, TELEPATCH CARDIAC MONITOR, OPSUMIT, JARDIANCE, SHINGRIX, FFRct, VERQUVO.
Industry payments across NY — which companies pay providers there.
